ClinicalTrials.govpublic full text
Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
leukemia, recurrent adult acute myeloid leukemia, philadelphia chromosome positive chronic myelogenous leukemia, secondary acute myeloid leukemia, blastic phase chronic myelogenous leukemia, relapsing chronic myelogenous leukemia, adult acute monocytic leukemia (m5b), adult acute erythroid leukemia (m6), adult acute megakaryoblastic leukemia (m7), adult acute minimally differentiated myeloid leukemia (m0), adult acute myeloblastic leukemia with maturation (m2), adult acute myeloblastic leukemia without maturation (m1)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 910204
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.